Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Result
of your search per sponsor: Antonio Colombo, MD
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
MASCOT - Post Marketing Registry
To collect post marketing surveillance data on patients receiving at least one Combo Bio-Engineered Sirolimus Eluting Stent when used according to the Instructions for Use. Data will be co...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
Percutaneous Treatment of Tricuspid Valve Regurgitation With the TriCinch System™
The TriCinch System™ is intended for percutaneous treatment of tricuspid regurgitation. It is a percutaneous catheter-based device designed for tricuspid valve repair in order to decrease...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
Clinical Performance of CRE8 Drug Eluting Stent in All Comer Population
The aim of this study is to evaluate safety and efficacy performances of CRE8 Drug Eluting Stent, in patients comparable to the everyday's clinical practice population, with a specific foc...
Country
Austria
,
Belgium
,
Italy
,
Netherlands
,
Norway
,
Poland
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
Evaluation of Platelet Function After Statin Loading Dose in Patients Before Percutaneous Coronary Intervention
The purpose of this study is to evaluate the effect of a loading dose of two different statins on platelet reactivity (atorvastatin, metabolized by CYP3A4, and rosuvastatin, which is rathe...
Country
Italy
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
Activity of Platelets After Inhibition and Cardiovascular Events Optical Coherence Tomography Study
It is an exploratory study evaluating a biological effect (stent strut coverage) using a novel technology such as OCT without any clinical implication.
Country
Italy
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
A Randomized, Double-Blind, Controlled Study of the Safety and Performance of the NIRx™ Paclitaxel-Coated Conformer Coronary Stent
The clinical investigation is an international, prospective, double-blind, randomized safety and efficacy study. The purpose of this study is to evaluate the safety and performance of the ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
Safety and Efficacy Study of the Amaranth Medical MAGNITUDE Bioresorbable Drug-Eluting Coronary Stent (RENASCENT III)
The purpose of this study is to evaluate the safety and performance of a new version of a coronary artery stent for treating blockages in the arteries supplying blood to the heart muscle. ...
Country
None
organs
None
Specialty
None
Opened trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD, PhD
Update Il y a 5 ans
The Study of the Crushing Technique Application Using SES in Coronary Bifurcations
The objective of this study is to compare the safety and effectiveness of two different approaches to treat bifurcational lesions with CYPHER SELECT™ Sirolimus-eluting Balloon-expandable C...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
Safety and Efficacy Study of the Amaranth Medical APTITUDE Bioresorbable Drug-Eluting Coronary Stent
The purpose of this study is to evaluate the safety and performance of a new version of a coronary artery stent for treating blockages in the arteries supplying blood to the heart muscle. ...
Country
None
organs
None
Specialty
None
Closed trial
More information
Woman and Man Max 99 years
Antonio Colombo, MD
Update Il y a 5 ans
The European Cobalt STent With Antiproliferative for Restenosis Trial (EuroSTAR Trial)
Two consecutive cohorts of subjects were each treated with the CoStar stent loaded with a different paclitaxel dose regimen. The first 145 subjects (Arm I), enrolled between 20 January 200...
Country
None
organs
None
Specialty
None
Closed trial
More information
1
2
Next